Boudreau Helen M — SEC Form 4 filings
SEC reporting owner CIK 1661481. 12 Form 4 filings on record with FilingPulse; latest filed 2026-07-10.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-05-16 to 2026-07-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 3 filings — 11,129 shares, $230,896 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: sale of 6,629 shares @ $19.85 ($131,586) in Premier, Inc., filed 2024-05-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Premier, Inc. (PINC) | Director | 5 | — | 3 legs · 11,129 sh · $230,896 | 2 |
| Rallybio Corp (RLYB) | Director | 3 | — | — | 4 |
| Shattuck Labs, Inc. (STTK) | Director | 3 | — | — | 3 |
| Cara Therapeutics, Inc. (CARA) | Director | 1 | — | — | 2 |
Form 4 filings — Boudreau Helen M
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-10 | 4 | Rallybio Corp (RLYB) | Option exercise (M): 3,562 @ $2.38 · Option exercise (M): 3,562 (derivative) @ $0 | EDGAR |
| 2026-06-02 | 4 | Shattuck Labs, Inc. (STTK) | Grant/award (A): 81,000 (derivative) @ $0 | EDGAR |
| 2025-11-26 | 4 | Premier, Inc. (PINC) | Disposition to issuer (D): 18,668 @ $28.25 | EDGAR |
| 2025-07-16 | 4 | Shattuck Labs, Inc. (STTK) | Grant/award (A): 33,150 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | Premier, Inc. (PINC) | Sale (S): 2,000 @ $22.88 | EDGAR |
| 2025-05-15 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 28,500 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | Premier, Inc. (PINC) | Sale (S): 2,500 @ $21.42 | EDGAR |
| 2024-12-10 | 4 | Premier, Inc. (PINC) | Grant/award (A): 7,101 @ $0 | EDGAR |
| 2024-06-21 | 4 | Shattuck Labs, Inc. (STTK) | Grant/award (A): 27,700 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | Cara Therapeutics, Inc. (CARA) | Grant/award (A): 150,647 @ $0 · Grant/award (A): 195,000 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 16,500 (derivative) @ $0 | EDGAR |
| 2024-05-16 | 4 | Premier, Inc. (PINC) | Sale (S): 6,629 @ $19.85 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1661481 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →